Precision SafetyDeveloping
FDA Flagged a Rare Genetic Anesthesia Safety Signal
FDA is investigating rare catastrophic neurologic outcomes after sevoflurane anesthesia in patients of maternal Venezuelan ancestry, with a mitochondrial variant reported in some cases.
Why now
FDA's alert creates an immediate clinician-awareness and family-history question before anesthesia in a specific ancestry-linked risk context.
- Overclaim risk
- high
- Primary source
- Official
- Published
- Jul 5, 2026